ppt on published research paper

14
Seminar on, Recent Trends in Pharmaceutical Sciences (Research Paper Title: Uptake and transport of furanodiene in Caco-2 cell monolayers: a comparison study between furanodiene and furanodiene loaded PLGA nanoparticles) BY: Nitin P. Kanwale Roll no. 06 M. Pharm. Sem III Dept. QAT UNDER GUIDANCE OF: Dr. Mrudula H. Bele (Pharmaceutics department) MVP Samaj's college of Pharmacy, Nashik MVP Samaj’s College of Pharmacy, Nashik 21/02/2022 1

Upload: nitin-kanwale

Post on 11-Jan-2017

202 views

Category:

Health & Medicine


3 download

TRANSCRIPT

Seminar onRecent Trends in Pharmaceutical Sciences

(Research Paper Title Uptake and transport of furanodiene in Caco-2 cellmonolayers a comparison study between furanodiene and furanodiene loaded PLGA nanoparticles)

BY Nitin P Kanwale

Roll no 06M Pharm Sem III

Dept QATUNDER GUIDANCE OFDr Mrudula H Bele

(Pharmaceutics department)MVP Samajs college of Pharmacy Nashik

MVP Samajrsquos College of Pharmacy Nashik01052023 1

CONTENTS1 Drug profile2 Introduction3 Preparation of FDE-PLGA-NPs and FDE-PEG-PLGA-

NPs4 Characterization of FDE-PLGA-NPs And FDE-PEG-

PEGA-NPs5 Conclusion6 References

01052023 2

3

1DRUG PROFILE

FURANODIENE

Stucture

Chemical name(5E9E)-3610-trimethyl-47811-tetrahydrocyclodeca[b]furan

Pharmacological activities

Anti-tumor Anti-inflammation

01052023

4

2 INTRODUCTIONRESEARCH QUESTION As it possible to improve the stability and bioavailability of FDE by preparing FDE loaded PLGA and PEGylated PLGA nanoparticles

GOAL OF WORK furanodiene has some disadvantages like low aqueous solubility low stability low permeability uptake by cell so there is need to improve the stability and oral bioavailability of furanodiene

Use Caco-2 cell line as a in vitro model to evaluate the response of Caco-2 cells to FDE FDE-PLGA-NPs and FDE-PEG-PLGA-NPs to compare the capacity of the carrier to mediate FDE transport across cell monolayers

01052023

3 Preparation of FDE-PLGA-NPs and FDE-PEG-PLGA-NPsbull By using modified spontaneous emulsion solvent diffusion

method

3 mg furanodiene+25 mg PLGA(PEG-PLGA) dissolved in 2 ml acetone slowelly injected into 15 ml of 02 tween80 solution magnetic stirring at room temp to evaporate the organic solvent

nanoparticle suspension was collected by centrifugation(15000 rpmmin) wash 3 times by using deionized water to remove excessive emulsifier nanoparticle suspension then freeze dried to obtain a fine power of nanoparticle

01052023 5

4 CHARACTERIZATION OF FDE-PLGA-NPs AND FDE-PEG-PEGA-NPsbull 41Nanoparticle size size distribution zeta potential surface

morphology entrapment efficiency EE= (T-F) Ttimes100 Where T= total amount of furanodiene added F= free furanodiene amount in the supernatant Table1 Characteristics of the nanoparticles

Fig 1 Scanning electron microscope (SEM) images of the nanoparticles Scale bar = 200 nm (a) FDE-PLGA-NPs (b) FDE-PEG-PLGA-NPs

01052023 6

42 In vitro stability studies

01052023 7

Fig 2 Stabilities of FDE FDE-PLGA-NPs and FDE-PEG-PLGA- Fig 3 Stabilities of FDE FDE-PLGA-NPs and FDE- NPs in PBS (pH 74) PEG-PLGA-NPs in artificial gastric fluids

Fig 4 Stabilities of FDE FDE-PLGA-NPs and FDE-PEG-PLGA-NPs in artificial intestinal fluids

43 Cytotoxicity test

Fig 5 The cytotoxicity of FDE FDE-PLGA-NPs and FDE-PEG-PLGA-NPs Caco-2 cells were incubated with sample solutions (1 to 40 μgminus1 of FDE) for 6 h Cell viability was determined by MTT assay

01052023 8

44 CELLULAR UPTAKE STUDY

Fig 6 Quantitative analysis of FDE cellular uptake Caco-2 cells were incubated with sample solutions (15 μgmLminus1 of FDE) for different durations Intracellular FDE was assayed by RP-HPLC

01052023 9

45 Transport study

Where Papp= Apparent permeability coefficient dq= amount of FDE in the receptor compartment at time t A = diffusion area C0 = initial concentration of FDE in the donor compartment

01052023 10

Papp

Fig 7 Transport of FDE across Caco-2 cell monolayers (AP to BL )

Fig 9 Transport of FDE across Caco-2 cell monolayers (BL to AP )

01052023 11

5CONCLUSIONThese results indicated that FDE-PLGA-NPs especially FDE-PEG-PLGA-NPs could enhance the stability and hydrophilicity of FDE and increase the permeation of FDE across Caco-2 cell monolayers

01052023 12

OVER VIEWPOSITIVE POINT

NEGATIVE POINT

6 REFERENCES1 Gang L Dong-hai L Xin-xin X Li-fang Q Jun-teng W Ke L

Uptake And Transport Of Furanodiene In Caco-2 Cell Monolayers A Comparison Study Between Furanodiene And Furanodiene Loaded PLGA Nanoparticles Chinese Journal Of Natural Medicines201311(1)049-055

01052023 13

14

01052023

  • Slide 1
  • CONTENTS
  • 1DRUG PROFILE
  • 2 INTRODUCTION
  • 3 Preparation of FDE-PLGA-NPs and FDE-PEG-PLGA-NPs
  • 4 CHARACTERIZATION OF FDE-PLGA-NPs AND FDE-PEG-PEGA-NPs
  • 42 In vitro stability studies
  • 43 Cytotoxicity test
  • 44 CELLULAR UPTAKE STUDY
  • 45 Transport study
  • Slide 11
  • 5CONCLUSION
  • 6 REFERENCES
  • Slide 14

CONTENTS1 Drug profile2 Introduction3 Preparation of FDE-PLGA-NPs and FDE-PEG-PLGA-

NPs4 Characterization of FDE-PLGA-NPs And FDE-PEG-

PEGA-NPs5 Conclusion6 References

01052023 2

3

1DRUG PROFILE

FURANODIENE

Stucture

Chemical name(5E9E)-3610-trimethyl-47811-tetrahydrocyclodeca[b]furan

Pharmacological activities

Anti-tumor Anti-inflammation

01052023

4

2 INTRODUCTIONRESEARCH QUESTION As it possible to improve the stability and bioavailability of FDE by preparing FDE loaded PLGA and PEGylated PLGA nanoparticles

GOAL OF WORK furanodiene has some disadvantages like low aqueous solubility low stability low permeability uptake by cell so there is need to improve the stability and oral bioavailability of furanodiene

Use Caco-2 cell line as a in vitro model to evaluate the response of Caco-2 cells to FDE FDE-PLGA-NPs and FDE-PEG-PLGA-NPs to compare the capacity of the carrier to mediate FDE transport across cell monolayers

01052023

3 Preparation of FDE-PLGA-NPs and FDE-PEG-PLGA-NPsbull By using modified spontaneous emulsion solvent diffusion

method

3 mg furanodiene+25 mg PLGA(PEG-PLGA) dissolved in 2 ml acetone slowelly injected into 15 ml of 02 tween80 solution magnetic stirring at room temp to evaporate the organic solvent

nanoparticle suspension was collected by centrifugation(15000 rpmmin) wash 3 times by using deionized water to remove excessive emulsifier nanoparticle suspension then freeze dried to obtain a fine power of nanoparticle

01052023 5

4 CHARACTERIZATION OF FDE-PLGA-NPs AND FDE-PEG-PEGA-NPsbull 41Nanoparticle size size distribution zeta potential surface

morphology entrapment efficiency EE= (T-F) Ttimes100 Where T= total amount of furanodiene added F= free furanodiene amount in the supernatant Table1 Characteristics of the nanoparticles

Fig 1 Scanning electron microscope (SEM) images of the nanoparticles Scale bar = 200 nm (a) FDE-PLGA-NPs (b) FDE-PEG-PLGA-NPs

01052023 6

42 In vitro stability studies

01052023 7

Fig 2 Stabilities of FDE FDE-PLGA-NPs and FDE-PEG-PLGA- Fig 3 Stabilities of FDE FDE-PLGA-NPs and FDE- NPs in PBS (pH 74) PEG-PLGA-NPs in artificial gastric fluids

Fig 4 Stabilities of FDE FDE-PLGA-NPs and FDE-PEG-PLGA-NPs in artificial intestinal fluids

43 Cytotoxicity test

Fig 5 The cytotoxicity of FDE FDE-PLGA-NPs and FDE-PEG-PLGA-NPs Caco-2 cells were incubated with sample solutions (1 to 40 μgminus1 of FDE) for 6 h Cell viability was determined by MTT assay

01052023 8

44 CELLULAR UPTAKE STUDY

Fig 6 Quantitative analysis of FDE cellular uptake Caco-2 cells were incubated with sample solutions (15 μgmLminus1 of FDE) for different durations Intracellular FDE was assayed by RP-HPLC

01052023 9

45 Transport study

Where Papp= Apparent permeability coefficient dq= amount of FDE in the receptor compartment at time t A = diffusion area C0 = initial concentration of FDE in the donor compartment

01052023 10

Papp

Fig 7 Transport of FDE across Caco-2 cell monolayers (AP to BL )

Fig 9 Transport of FDE across Caco-2 cell monolayers (BL to AP )

01052023 11

5CONCLUSIONThese results indicated that FDE-PLGA-NPs especially FDE-PEG-PLGA-NPs could enhance the stability and hydrophilicity of FDE and increase the permeation of FDE across Caco-2 cell monolayers

01052023 12

OVER VIEWPOSITIVE POINT

NEGATIVE POINT

6 REFERENCES1 Gang L Dong-hai L Xin-xin X Li-fang Q Jun-teng W Ke L

Uptake And Transport Of Furanodiene In Caco-2 Cell Monolayers A Comparison Study Between Furanodiene And Furanodiene Loaded PLGA Nanoparticles Chinese Journal Of Natural Medicines201311(1)049-055

01052023 13

14

01052023

  • Slide 1
  • CONTENTS
  • 1DRUG PROFILE
  • 2 INTRODUCTION
  • 3 Preparation of FDE-PLGA-NPs and FDE-PEG-PLGA-NPs
  • 4 CHARACTERIZATION OF FDE-PLGA-NPs AND FDE-PEG-PEGA-NPs
  • 42 In vitro stability studies
  • 43 Cytotoxicity test
  • 44 CELLULAR UPTAKE STUDY
  • 45 Transport study
  • Slide 11
  • 5CONCLUSION
  • 6 REFERENCES
  • Slide 14

3

1DRUG PROFILE

FURANODIENE

Stucture

Chemical name(5E9E)-3610-trimethyl-47811-tetrahydrocyclodeca[b]furan

Pharmacological activities

Anti-tumor Anti-inflammation

01052023

4

2 INTRODUCTIONRESEARCH QUESTION As it possible to improve the stability and bioavailability of FDE by preparing FDE loaded PLGA and PEGylated PLGA nanoparticles

GOAL OF WORK furanodiene has some disadvantages like low aqueous solubility low stability low permeability uptake by cell so there is need to improve the stability and oral bioavailability of furanodiene

Use Caco-2 cell line as a in vitro model to evaluate the response of Caco-2 cells to FDE FDE-PLGA-NPs and FDE-PEG-PLGA-NPs to compare the capacity of the carrier to mediate FDE transport across cell monolayers

01052023

3 Preparation of FDE-PLGA-NPs and FDE-PEG-PLGA-NPsbull By using modified spontaneous emulsion solvent diffusion

method

3 mg furanodiene+25 mg PLGA(PEG-PLGA) dissolved in 2 ml acetone slowelly injected into 15 ml of 02 tween80 solution magnetic stirring at room temp to evaporate the organic solvent

nanoparticle suspension was collected by centrifugation(15000 rpmmin) wash 3 times by using deionized water to remove excessive emulsifier nanoparticle suspension then freeze dried to obtain a fine power of nanoparticle

01052023 5

4 CHARACTERIZATION OF FDE-PLGA-NPs AND FDE-PEG-PEGA-NPsbull 41Nanoparticle size size distribution zeta potential surface

morphology entrapment efficiency EE= (T-F) Ttimes100 Where T= total amount of furanodiene added F= free furanodiene amount in the supernatant Table1 Characteristics of the nanoparticles

Fig 1 Scanning electron microscope (SEM) images of the nanoparticles Scale bar = 200 nm (a) FDE-PLGA-NPs (b) FDE-PEG-PLGA-NPs

01052023 6

42 In vitro stability studies

01052023 7

Fig 2 Stabilities of FDE FDE-PLGA-NPs and FDE-PEG-PLGA- Fig 3 Stabilities of FDE FDE-PLGA-NPs and FDE- NPs in PBS (pH 74) PEG-PLGA-NPs in artificial gastric fluids

Fig 4 Stabilities of FDE FDE-PLGA-NPs and FDE-PEG-PLGA-NPs in artificial intestinal fluids

43 Cytotoxicity test

Fig 5 The cytotoxicity of FDE FDE-PLGA-NPs and FDE-PEG-PLGA-NPs Caco-2 cells were incubated with sample solutions (1 to 40 μgminus1 of FDE) for 6 h Cell viability was determined by MTT assay

01052023 8

44 CELLULAR UPTAKE STUDY

Fig 6 Quantitative analysis of FDE cellular uptake Caco-2 cells were incubated with sample solutions (15 μgmLminus1 of FDE) for different durations Intracellular FDE was assayed by RP-HPLC

01052023 9

45 Transport study

Where Papp= Apparent permeability coefficient dq= amount of FDE in the receptor compartment at time t A = diffusion area C0 = initial concentration of FDE in the donor compartment

01052023 10

Papp

Fig 7 Transport of FDE across Caco-2 cell monolayers (AP to BL )

Fig 9 Transport of FDE across Caco-2 cell monolayers (BL to AP )

01052023 11

5CONCLUSIONThese results indicated that FDE-PLGA-NPs especially FDE-PEG-PLGA-NPs could enhance the stability and hydrophilicity of FDE and increase the permeation of FDE across Caco-2 cell monolayers

01052023 12

OVER VIEWPOSITIVE POINT

NEGATIVE POINT

6 REFERENCES1 Gang L Dong-hai L Xin-xin X Li-fang Q Jun-teng W Ke L

Uptake And Transport Of Furanodiene In Caco-2 Cell Monolayers A Comparison Study Between Furanodiene And Furanodiene Loaded PLGA Nanoparticles Chinese Journal Of Natural Medicines201311(1)049-055

01052023 13

14

01052023

  • Slide 1
  • CONTENTS
  • 1DRUG PROFILE
  • 2 INTRODUCTION
  • 3 Preparation of FDE-PLGA-NPs and FDE-PEG-PLGA-NPs
  • 4 CHARACTERIZATION OF FDE-PLGA-NPs AND FDE-PEG-PEGA-NPs
  • 42 In vitro stability studies
  • 43 Cytotoxicity test
  • 44 CELLULAR UPTAKE STUDY
  • 45 Transport study
  • Slide 11
  • 5CONCLUSION
  • 6 REFERENCES
  • Slide 14

4

2 INTRODUCTIONRESEARCH QUESTION As it possible to improve the stability and bioavailability of FDE by preparing FDE loaded PLGA and PEGylated PLGA nanoparticles

GOAL OF WORK furanodiene has some disadvantages like low aqueous solubility low stability low permeability uptake by cell so there is need to improve the stability and oral bioavailability of furanodiene

Use Caco-2 cell line as a in vitro model to evaluate the response of Caco-2 cells to FDE FDE-PLGA-NPs and FDE-PEG-PLGA-NPs to compare the capacity of the carrier to mediate FDE transport across cell monolayers

01052023

3 Preparation of FDE-PLGA-NPs and FDE-PEG-PLGA-NPsbull By using modified spontaneous emulsion solvent diffusion

method

3 mg furanodiene+25 mg PLGA(PEG-PLGA) dissolved in 2 ml acetone slowelly injected into 15 ml of 02 tween80 solution magnetic stirring at room temp to evaporate the organic solvent

nanoparticle suspension was collected by centrifugation(15000 rpmmin) wash 3 times by using deionized water to remove excessive emulsifier nanoparticle suspension then freeze dried to obtain a fine power of nanoparticle

01052023 5

4 CHARACTERIZATION OF FDE-PLGA-NPs AND FDE-PEG-PEGA-NPsbull 41Nanoparticle size size distribution zeta potential surface

morphology entrapment efficiency EE= (T-F) Ttimes100 Where T= total amount of furanodiene added F= free furanodiene amount in the supernatant Table1 Characteristics of the nanoparticles

Fig 1 Scanning electron microscope (SEM) images of the nanoparticles Scale bar = 200 nm (a) FDE-PLGA-NPs (b) FDE-PEG-PLGA-NPs

01052023 6

42 In vitro stability studies

01052023 7

Fig 2 Stabilities of FDE FDE-PLGA-NPs and FDE-PEG-PLGA- Fig 3 Stabilities of FDE FDE-PLGA-NPs and FDE- NPs in PBS (pH 74) PEG-PLGA-NPs in artificial gastric fluids

Fig 4 Stabilities of FDE FDE-PLGA-NPs and FDE-PEG-PLGA-NPs in artificial intestinal fluids

43 Cytotoxicity test

Fig 5 The cytotoxicity of FDE FDE-PLGA-NPs and FDE-PEG-PLGA-NPs Caco-2 cells were incubated with sample solutions (1 to 40 μgminus1 of FDE) for 6 h Cell viability was determined by MTT assay

01052023 8

44 CELLULAR UPTAKE STUDY

Fig 6 Quantitative analysis of FDE cellular uptake Caco-2 cells were incubated with sample solutions (15 μgmLminus1 of FDE) for different durations Intracellular FDE was assayed by RP-HPLC

01052023 9

45 Transport study

Where Papp= Apparent permeability coefficient dq= amount of FDE in the receptor compartment at time t A = diffusion area C0 = initial concentration of FDE in the donor compartment

01052023 10

Papp

Fig 7 Transport of FDE across Caco-2 cell monolayers (AP to BL )

Fig 9 Transport of FDE across Caco-2 cell monolayers (BL to AP )

01052023 11

5CONCLUSIONThese results indicated that FDE-PLGA-NPs especially FDE-PEG-PLGA-NPs could enhance the stability and hydrophilicity of FDE and increase the permeation of FDE across Caco-2 cell monolayers

01052023 12

OVER VIEWPOSITIVE POINT

NEGATIVE POINT

6 REFERENCES1 Gang L Dong-hai L Xin-xin X Li-fang Q Jun-teng W Ke L

Uptake And Transport Of Furanodiene In Caco-2 Cell Monolayers A Comparison Study Between Furanodiene And Furanodiene Loaded PLGA Nanoparticles Chinese Journal Of Natural Medicines201311(1)049-055

01052023 13

14

01052023

  • Slide 1
  • CONTENTS
  • 1DRUG PROFILE
  • 2 INTRODUCTION
  • 3 Preparation of FDE-PLGA-NPs and FDE-PEG-PLGA-NPs
  • 4 CHARACTERIZATION OF FDE-PLGA-NPs AND FDE-PEG-PEGA-NPs
  • 42 In vitro stability studies
  • 43 Cytotoxicity test
  • 44 CELLULAR UPTAKE STUDY
  • 45 Transport study
  • Slide 11
  • 5CONCLUSION
  • 6 REFERENCES
  • Slide 14

3 Preparation of FDE-PLGA-NPs and FDE-PEG-PLGA-NPsbull By using modified spontaneous emulsion solvent diffusion

method

3 mg furanodiene+25 mg PLGA(PEG-PLGA) dissolved in 2 ml acetone slowelly injected into 15 ml of 02 tween80 solution magnetic stirring at room temp to evaporate the organic solvent

nanoparticle suspension was collected by centrifugation(15000 rpmmin) wash 3 times by using deionized water to remove excessive emulsifier nanoparticle suspension then freeze dried to obtain a fine power of nanoparticle

01052023 5

4 CHARACTERIZATION OF FDE-PLGA-NPs AND FDE-PEG-PEGA-NPsbull 41Nanoparticle size size distribution zeta potential surface

morphology entrapment efficiency EE= (T-F) Ttimes100 Where T= total amount of furanodiene added F= free furanodiene amount in the supernatant Table1 Characteristics of the nanoparticles

Fig 1 Scanning electron microscope (SEM) images of the nanoparticles Scale bar = 200 nm (a) FDE-PLGA-NPs (b) FDE-PEG-PLGA-NPs

01052023 6

42 In vitro stability studies

01052023 7

Fig 2 Stabilities of FDE FDE-PLGA-NPs and FDE-PEG-PLGA- Fig 3 Stabilities of FDE FDE-PLGA-NPs and FDE- NPs in PBS (pH 74) PEG-PLGA-NPs in artificial gastric fluids

Fig 4 Stabilities of FDE FDE-PLGA-NPs and FDE-PEG-PLGA-NPs in artificial intestinal fluids

43 Cytotoxicity test

Fig 5 The cytotoxicity of FDE FDE-PLGA-NPs and FDE-PEG-PLGA-NPs Caco-2 cells were incubated with sample solutions (1 to 40 μgminus1 of FDE) for 6 h Cell viability was determined by MTT assay

01052023 8

44 CELLULAR UPTAKE STUDY

Fig 6 Quantitative analysis of FDE cellular uptake Caco-2 cells were incubated with sample solutions (15 μgmLminus1 of FDE) for different durations Intracellular FDE was assayed by RP-HPLC

01052023 9

45 Transport study

Where Papp= Apparent permeability coefficient dq= amount of FDE in the receptor compartment at time t A = diffusion area C0 = initial concentration of FDE in the donor compartment

01052023 10

Papp

Fig 7 Transport of FDE across Caco-2 cell monolayers (AP to BL )

Fig 9 Transport of FDE across Caco-2 cell monolayers (BL to AP )

01052023 11

5CONCLUSIONThese results indicated that FDE-PLGA-NPs especially FDE-PEG-PLGA-NPs could enhance the stability and hydrophilicity of FDE and increase the permeation of FDE across Caco-2 cell monolayers

01052023 12

OVER VIEWPOSITIVE POINT

NEGATIVE POINT

6 REFERENCES1 Gang L Dong-hai L Xin-xin X Li-fang Q Jun-teng W Ke L

Uptake And Transport Of Furanodiene In Caco-2 Cell Monolayers A Comparison Study Between Furanodiene And Furanodiene Loaded PLGA Nanoparticles Chinese Journal Of Natural Medicines201311(1)049-055

01052023 13

14

01052023

  • Slide 1
  • CONTENTS
  • 1DRUG PROFILE
  • 2 INTRODUCTION
  • 3 Preparation of FDE-PLGA-NPs and FDE-PEG-PLGA-NPs
  • 4 CHARACTERIZATION OF FDE-PLGA-NPs AND FDE-PEG-PEGA-NPs
  • 42 In vitro stability studies
  • 43 Cytotoxicity test
  • 44 CELLULAR UPTAKE STUDY
  • 45 Transport study
  • Slide 11
  • 5CONCLUSION
  • 6 REFERENCES
  • Slide 14

4 CHARACTERIZATION OF FDE-PLGA-NPs AND FDE-PEG-PEGA-NPsbull 41Nanoparticle size size distribution zeta potential surface

morphology entrapment efficiency EE= (T-F) Ttimes100 Where T= total amount of furanodiene added F= free furanodiene amount in the supernatant Table1 Characteristics of the nanoparticles

Fig 1 Scanning electron microscope (SEM) images of the nanoparticles Scale bar = 200 nm (a) FDE-PLGA-NPs (b) FDE-PEG-PLGA-NPs

01052023 6

42 In vitro stability studies

01052023 7

Fig 2 Stabilities of FDE FDE-PLGA-NPs and FDE-PEG-PLGA- Fig 3 Stabilities of FDE FDE-PLGA-NPs and FDE- NPs in PBS (pH 74) PEG-PLGA-NPs in artificial gastric fluids

Fig 4 Stabilities of FDE FDE-PLGA-NPs and FDE-PEG-PLGA-NPs in artificial intestinal fluids

43 Cytotoxicity test

Fig 5 The cytotoxicity of FDE FDE-PLGA-NPs and FDE-PEG-PLGA-NPs Caco-2 cells were incubated with sample solutions (1 to 40 μgminus1 of FDE) for 6 h Cell viability was determined by MTT assay

01052023 8

44 CELLULAR UPTAKE STUDY

Fig 6 Quantitative analysis of FDE cellular uptake Caco-2 cells were incubated with sample solutions (15 μgmLminus1 of FDE) for different durations Intracellular FDE was assayed by RP-HPLC

01052023 9

45 Transport study

Where Papp= Apparent permeability coefficient dq= amount of FDE in the receptor compartment at time t A = diffusion area C0 = initial concentration of FDE in the donor compartment

01052023 10

Papp

Fig 7 Transport of FDE across Caco-2 cell monolayers (AP to BL )

Fig 9 Transport of FDE across Caco-2 cell monolayers (BL to AP )

01052023 11

5CONCLUSIONThese results indicated that FDE-PLGA-NPs especially FDE-PEG-PLGA-NPs could enhance the stability and hydrophilicity of FDE and increase the permeation of FDE across Caco-2 cell monolayers

01052023 12

OVER VIEWPOSITIVE POINT

NEGATIVE POINT

6 REFERENCES1 Gang L Dong-hai L Xin-xin X Li-fang Q Jun-teng W Ke L

Uptake And Transport Of Furanodiene In Caco-2 Cell Monolayers A Comparison Study Between Furanodiene And Furanodiene Loaded PLGA Nanoparticles Chinese Journal Of Natural Medicines201311(1)049-055

01052023 13

14

01052023

  • Slide 1
  • CONTENTS
  • 1DRUG PROFILE
  • 2 INTRODUCTION
  • 3 Preparation of FDE-PLGA-NPs and FDE-PEG-PLGA-NPs
  • 4 CHARACTERIZATION OF FDE-PLGA-NPs AND FDE-PEG-PEGA-NPs
  • 42 In vitro stability studies
  • 43 Cytotoxicity test
  • 44 CELLULAR UPTAKE STUDY
  • 45 Transport study
  • Slide 11
  • 5CONCLUSION
  • 6 REFERENCES
  • Slide 14

42 In vitro stability studies

01052023 7

Fig 2 Stabilities of FDE FDE-PLGA-NPs and FDE-PEG-PLGA- Fig 3 Stabilities of FDE FDE-PLGA-NPs and FDE- NPs in PBS (pH 74) PEG-PLGA-NPs in artificial gastric fluids

Fig 4 Stabilities of FDE FDE-PLGA-NPs and FDE-PEG-PLGA-NPs in artificial intestinal fluids

43 Cytotoxicity test

Fig 5 The cytotoxicity of FDE FDE-PLGA-NPs and FDE-PEG-PLGA-NPs Caco-2 cells were incubated with sample solutions (1 to 40 μgminus1 of FDE) for 6 h Cell viability was determined by MTT assay

01052023 8

44 CELLULAR UPTAKE STUDY

Fig 6 Quantitative analysis of FDE cellular uptake Caco-2 cells were incubated with sample solutions (15 μgmLminus1 of FDE) for different durations Intracellular FDE was assayed by RP-HPLC

01052023 9

45 Transport study

Where Papp= Apparent permeability coefficient dq= amount of FDE in the receptor compartment at time t A = diffusion area C0 = initial concentration of FDE in the donor compartment

01052023 10

Papp

Fig 7 Transport of FDE across Caco-2 cell monolayers (AP to BL )

Fig 9 Transport of FDE across Caco-2 cell monolayers (BL to AP )

01052023 11

5CONCLUSIONThese results indicated that FDE-PLGA-NPs especially FDE-PEG-PLGA-NPs could enhance the stability and hydrophilicity of FDE and increase the permeation of FDE across Caco-2 cell monolayers

01052023 12

OVER VIEWPOSITIVE POINT

NEGATIVE POINT

6 REFERENCES1 Gang L Dong-hai L Xin-xin X Li-fang Q Jun-teng W Ke L

Uptake And Transport Of Furanodiene In Caco-2 Cell Monolayers A Comparison Study Between Furanodiene And Furanodiene Loaded PLGA Nanoparticles Chinese Journal Of Natural Medicines201311(1)049-055

01052023 13

14

01052023

  • Slide 1
  • CONTENTS
  • 1DRUG PROFILE
  • 2 INTRODUCTION
  • 3 Preparation of FDE-PLGA-NPs and FDE-PEG-PLGA-NPs
  • 4 CHARACTERIZATION OF FDE-PLGA-NPs AND FDE-PEG-PEGA-NPs
  • 42 In vitro stability studies
  • 43 Cytotoxicity test
  • 44 CELLULAR UPTAKE STUDY
  • 45 Transport study
  • Slide 11
  • 5CONCLUSION
  • 6 REFERENCES
  • Slide 14

43 Cytotoxicity test

Fig 5 The cytotoxicity of FDE FDE-PLGA-NPs and FDE-PEG-PLGA-NPs Caco-2 cells were incubated with sample solutions (1 to 40 μgminus1 of FDE) for 6 h Cell viability was determined by MTT assay

01052023 8

44 CELLULAR UPTAKE STUDY

Fig 6 Quantitative analysis of FDE cellular uptake Caco-2 cells were incubated with sample solutions (15 μgmLminus1 of FDE) for different durations Intracellular FDE was assayed by RP-HPLC

01052023 9

45 Transport study

Where Papp= Apparent permeability coefficient dq= amount of FDE in the receptor compartment at time t A = diffusion area C0 = initial concentration of FDE in the donor compartment

01052023 10

Papp

Fig 7 Transport of FDE across Caco-2 cell monolayers (AP to BL )

Fig 9 Transport of FDE across Caco-2 cell monolayers (BL to AP )

01052023 11

5CONCLUSIONThese results indicated that FDE-PLGA-NPs especially FDE-PEG-PLGA-NPs could enhance the stability and hydrophilicity of FDE and increase the permeation of FDE across Caco-2 cell monolayers

01052023 12

OVER VIEWPOSITIVE POINT

NEGATIVE POINT

6 REFERENCES1 Gang L Dong-hai L Xin-xin X Li-fang Q Jun-teng W Ke L

Uptake And Transport Of Furanodiene In Caco-2 Cell Monolayers A Comparison Study Between Furanodiene And Furanodiene Loaded PLGA Nanoparticles Chinese Journal Of Natural Medicines201311(1)049-055

01052023 13

14

01052023

  • Slide 1
  • CONTENTS
  • 1DRUG PROFILE
  • 2 INTRODUCTION
  • 3 Preparation of FDE-PLGA-NPs and FDE-PEG-PLGA-NPs
  • 4 CHARACTERIZATION OF FDE-PLGA-NPs AND FDE-PEG-PEGA-NPs
  • 42 In vitro stability studies
  • 43 Cytotoxicity test
  • 44 CELLULAR UPTAKE STUDY
  • 45 Transport study
  • Slide 11
  • 5CONCLUSION
  • 6 REFERENCES
  • Slide 14

44 CELLULAR UPTAKE STUDY

Fig 6 Quantitative analysis of FDE cellular uptake Caco-2 cells were incubated with sample solutions (15 μgmLminus1 of FDE) for different durations Intracellular FDE was assayed by RP-HPLC

01052023 9

45 Transport study

Where Papp= Apparent permeability coefficient dq= amount of FDE in the receptor compartment at time t A = diffusion area C0 = initial concentration of FDE in the donor compartment

01052023 10

Papp

Fig 7 Transport of FDE across Caco-2 cell monolayers (AP to BL )

Fig 9 Transport of FDE across Caco-2 cell monolayers (BL to AP )

01052023 11

5CONCLUSIONThese results indicated that FDE-PLGA-NPs especially FDE-PEG-PLGA-NPs could enhance the stability and hydrophilicity of FDE and increase the permeation of FDE across Caco-2 cell monolayers

01052023 12

OVER VIEWPOSITIVE POINT

NEGATIVE POINT

6 REFERENCES1 Gang L Dong-hai L Xin-xin X Li-fang Q Jun-teng W Ke L

Uptake And Transport Of Furanodiene In Caco-2 Cell Monolayers A Comparison Study Between Furanodiene And Furanodiene Loaded PLGA Nanoparticles Chinese Journal Of Natural Medicines201311(1)049-055

01052023 13

14

01052023

  • Slide 1
  • CONTENTS
  • 1DRUG PROFILE
  • 2 INTRODUCTION
  • 3 Preparation of FDE-PLGA-NPs and FDE-PEG-PLGA-NPs
  • 4 CHARACTERIZATION OF FDE-PLGA-NPs AND FDE-PEG-PEGA-NPs
  • 42 In vitro stability studies
  • 43 Cytotoxicity test
  • 44 CELLULAR UPTAKE STUDY
  • 45 Transport study
  • Slide 11
  • 5CONCLUSION
  • 6 REFERENCES
  • Slide 14

45 Transport study

Where Papp= Apparent permeability coefficient dq= amount of FDE in the receptor compartment at time t A = diffusion area C0 = initial concentration of FDE in the donor compartment

01052023 10

Papp

Fig 7 Transport of FDE across Caco-2 cell monolayers (AP to BL )

Fig 9 Transport of FDE across Caco-2 cell monolayers (BL to AP )

01052023 11

5CONCLUSIONThese results indicated that FDE-PLGA-NPs especially FDE-PEG-PLGA-NPs could enhance the stability and hydrophilicity of FDE and increase the permeation of FDE across Caco-2 cell monolayers

01052023 12

OVER VIEWPOSITIVE POINT

NEGATIVE POINT

6 REFERENCES1 Gang L Dong-hai L Xin-xin X Li-fang Q Jun-teng W Ke L

Uptake And Transport Of Furanodiene In Caco-2 Cell Monolayers A Comparison Study Between Furanodiene And Furanodiene Loaded PLGA Nanoparticles Chinese Journal Of Natural Medicines201311(1)049-055

01052023 13

14

01052023

  • Slide 1
  • CONTENTS
  • 1DRUG PROFILE
  • 2 INTRODUCTION
  • 3 Preparation of FDE-PLGA-NPs and FDE-PEG-PLGA-NPs
  • 4 CHARACTERIZATION OF FDE-PLGA-NPs AND FDE-PEG-PEGA-NPs
  • 42 In vitro stability studies
  • 43 Cytotoxicity test
  • 44 CELLULAR UPTAKE STUDY
  • 45 Transport study
  • Slide 11
  • 5CONCLUSION
  • 6 REFERENCES
  • Slide 14

Fig 7 Transport of FDE across Caco-2 cell monolayers (AP to BL )

Fig 9 Transport of FDE across Caco-2 cell monolayers (BL to AP )

01052023 11

5CONCLUSIONThese results indicated that FDE-PLGA-NPs especially FDE-PEG-PLGA-NPs could enhance the stability and hydrophilicity of FDE and increase the permeation of FDE across Caco-2 cell monolayers

01052023 12

OVER VIEWPOSITIVE POINT

NEGATIVE POINT

6 REFERENCES1 Gang L Dong-hai L Xin-xin X Li-fang Q Jun-teng W Ke L

Uptake And Transport Of Furanodiene In Caco-2 Cell Monolayers A Comparison Study Between Furanodiene And Furanodiene Loaded PLGA Nanoparticles Chinese Journal Of Natural Medicines201311(1)049-055

01052023 13

14

01052023

  • Slide 1
  • CONTENTS
  • 1DRUG PROFILE
  • 2 INTRODUCTION
  • 3 Preparation of FDE-PLGA-NPs and FDE-PEG-PLGA-NPs
  • 4 CHARACTERIZATION OF FDE-PLGA-NPs AND FDE-PEG-PEGA-NPs
  • 42 In vitro stability studies
  • 43 Cytotoxicity test
  • 44 CELLULAR UPTAKE STUDY
  • 45 Transport study
  • Slide 11
  • 5CONCLUSION
  • 6 REFERENCES
  • Slide 14

5CONCLUSIONThese results indicated that FDE-PLGA-NPs especially FDE-PEG-PLGA-NPs could enhance the stability and hydrophilicity of FDE and increase the permeation of FDE across Caco-2 cell monolayers

01052023 12

OVER VIEWPOSITIVE POINT

NEGATIVE POINT

6 REFERENCES1 Gang L Dong-hai L Xin-xin X Li-fang Q Jun-teng W Ke L

Uptake And Transport Of Furanodiene In Caco-2 Cell Monolayers A Comparison Study Between Furanodiene And Furanodiene Loaded PLGA Nanoparticles Chinese Journal Of Natural Medicines201311(1)049-055

01052023 13

14

01052023

  • Slide 1
  • CONTENTS
  • 1DRUG PROFILE
  • 2 INTRODUCTION
  • 3 Preparation of FDE-PLGA-NPs and FDE-PEG-PLGA-NPs
  • 4 CHARACTERIZATION OF FDE-PLGA-NPs AND FDE-PEG-PEGA-NPs
  • 42 In vitro stability studies
  • 43 Cytotoxicity test
  • 44 CELLULAR UPTAKE STUDY
  • 45 Transport study
  • Slide 11
  • 5CONCLUSION
  • 6 REFERENCES
  • Slide 14

6 REFERENCES1 Gang L Dong-hai L Xin-xin X Li-fang Q Jun-teng W Ke L

Uptake And Transport Of Furanodiene In Caco-2 Cell Monolayers A Comparison Study Between Furanodiene And Furanodiene Loaded PLGA Nanoparticles Chinese Journal Of Natural Medicines201311(1)049-055

01052023 13

14

01052023

  • Slide 1
  • CONTENTS
  • 1DRUG PROFILE
  • 2 INTRODUCTION
  • 3 Preparation of FDE-PLGA-NPs and FDE-PEG-PLGA-NPs
  • 4 CHARACTERIZATION OF FDE-PLGA-NPs AND FDE-PEG-PEGA-NPs
  • 42 In vitro stability studies
  • 43 Cytotoxicity test
  • 44 CELLULAR UPTAKE STUDY
  • 45 Transport study
  • Slide 11
  • 5CONCLUSION
  • 6 REFERENCES
  • Slide 14

14

01052023

  • Slide 1
  • CONTENTS
  • 1DRUG PROFILE
  • 2 INTRODUCTION
  • 3 Preparation of FDE-PLGA-NPs and FDE-PEG-PLGA-NPs
  • 4 CHARACTERIZATION OF FDE-PLGA-NPs AND FDE-PEG-PEGA-NPs
  • 42 In vitro stability studies
  • 43 Cytotoxicity test
  • 44 CELLULAR UPTAKE STUDY
  • 45 Transport study
  • Slide 11
  • 5CONCLUSION
  • 6 REFERENCES
  • Slide 14